Nausea Control

**Nausea Control** is a symptom-management domain in palliative oncology that focuses on the systematic assessment, prevention, and alleviation of nausea in patients with cancer through coordinated pharmacologic and non-pharmacologic interventions aimed at reducing symptom burden and optimizing quality of life.

1.9K

Publications

90.6K

Citations

8.2K

Authors

2.5K

Institutions

Publications per year

2017–2026

314

Parents

Palliative Oncology

Children

Cannabinoid-based AntiemeticsNausea Severity ScalesNutritional Interventions For NauseaOlanzapine For Nausea ControlPregnancy-related NauseaVestibular Nausea

Publications

1.9K

A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting

Christian C. Apfel, K. Korttila, Mona Abdalla et al. · New England Journal of Medicine · 2004 · 1.6K citations · Full text

Medicine, Anesthesiology, Surgery +17

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Paul J. Hesketh, Steven M. Grunberg, Richard J. Gralla et al. · Journal of Clinical Oncology · 2003 · 776 citations

Medicine, Pharmacology, Pharmacotherapy +17

Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting

Richard J. Gralla, Loretta M. Itri, Sharon E. Pisko et al. · New England Journal of Medicine · 1981 · 710 citations

Medicine, Pharmacology, Pharmacotherapy +17

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting

S. Poli-Bigelli, José Rodrigues-Pereira, Alexandra D. Carides et al. · Cancer · 2003 · 566 citations

Medicine, Oncology, Pharmacology +17

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

Richard J. Gralla, M. Lichinitser, S. van der Vegt et al. · Annals of Oncology · 2003 · 471 citations

Medicine, Oncology, Pharmacology +17

1–5 of 1.9K

Authors

8.2K

GR
Gary R. Morrow
University of Rochester, United States
34 publications · 2.5K citations
25
h-index
SM
Steven M. Grunberg
University of Vermont, United States
29 publications · 3.8K citations
23
h-index
RM
Rudolph M. Navari
Indiana University South Bend, United States
32 publications · 2.6K citations
21
h-index
LA
Linda A. Parker
University of Guelph, Canada
28 publications · 1.3K citations
20
h-index
FR
Fausto Roila
Santa Maria Nuova Hospital, Italy
22 publications · 2.3K citations
20
h-index

1–5 of 8.2K

Institutions

2.5K

1–8 of 2.5K

Venues

PubMed
Repository · 220 publications · 7.2K citations
45
h-index
Journal of Clinical Oncology
74 publications · 6.3K citations
40
h-index
Supportive Care in Cancer
115 publications · 5.2K citations
39
h-index
Anesthesia & Analgesia
50 publications · 3.3K citations
32
h-index
British Journal of Anaesthesia
40 publications · 2.6K citations
31
h-index

1–5